Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 West, Janssen in Drug Delivery Alliance | Contract Pharma
Breaking News, Collaborations & Alliances

West, Janssen in Drug Delivery Alliance

To develop and manufacture self-injection technology

West has entered an agreement with Janssen Biotech for the development and manufacture of a new self-injection product. The technology, developed by Janssen, has been designed to facilitate easier self-injection of pharmaceutical and biologic drug products. West will market the new injection technology under the name SelfDose and will be responsible for co-development, commercial scale-up, and manufacture of the product.
 
“We are delighted to have formalized our relationship with Janssen Biotech around this drug delivery platform and look forward to working together to commercialize the SelfDose injection technology, providing manufacturing, development and regulatory support through the remainder of the process,” said Donald E. Morel, Jr., Ph.D., West’s chairman and chief executive officer. “We value the opportunity to strengthen our long-standing relationship and are excited by this agreement. We look forward to working with Janssen to help them meet their business goals to restore health and serve patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters